Consideration on prevention of phlebitis and venous pain from intravenous prostaglandin E1 administration by adjusting solution pH: in vitro manipulations affecting pH

DOI Web Site Web Site 参考文献12件

書誌事項

タイトル別名
  • Consideration on Prevention of Phlebitis and Venous Pain from Intravenous Prostaglandin E<sub>1</sub> Administration by Adjusting Solution pH: <i>In Vitro</i> Manipulations Affecting pH

この論文をさがす

抄録

  Prostaglandin E1 (PGE1; Alprostadil Alfadex) is a potent vasodilator and inhibitor of platelet aggregation used to treat patients with peripheral vascular disease. The main adverse effects of intravenous PGE1 administration, phlebitis and venous pain, arise from the unphysiologically low pH of infusion solutions. When PGE1 infusion solutions with a pH value greater then 6 are used, phlebitis and venous pain are considered to be avoidable. Beginning with a PGE1 infusion solution with pH greater than 6, we add the amount of 7% sodium bicarbonate needed to bring the solution to pH 7.4 if phlebitis or venous pain develops. In the present study we established a convenient nomogram showing the relationship between the titratable acidity of various infusion solutions and the volume of 7% sodium bicarbonate required to attain pH 7.4 for preventing the phlebitis and venous pain associated with PGE1 infusion.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 128 (1), 111-115, 2008-01-01

    公益社団法人 日本薬学会

参考文献 (12)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ